U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07273071) titled 'Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections' on Nov. 26.
Brief Summary: The goal of the IMPACT trial is to determine whether an individualized treatment strategy, initiated at admission to the Emergency Department, can reduce hospitalizations and improve survival among patients with sepsis. To address this question, we will enroll 300 participants in a randomized controlled trial.
All participants will undergo an extended clinical assessment. Those randomized to the individualized treatment arm may receive up to five targeted interventions, depending on the findings of this assessment.
The targ...